the present disclosure relates to drug eluting devices , and their uses . the drug eluting devices can allow for perfusion during deployment . the coatings the may contain bioactive materials which elute once deployed in a patient and can have anti - proliferative , anti - inflammation , or anti - thrombotic effects . sol gel technology can be used to coat the devices .